<DOC>
	<DOCNO>NCT00315510</DOCNO>
	<brief_summary>Statins , include rosuvastatin , drug low plasma cholesterol prevent atherosclerotic disease . Recent preclinical evidence suggest statin also increase tissue tolerance ischemia-reperfusion injury . This randomized , double blind , parallel design study compare effect 1 week treatment rosuvastatin ( 20 mg , day ) placebo forearm ischemia-reperfusion injury healthy male volunteer . Forearm ischemia-reperfusion injury quantify Tc-99m-annexin A5 scintigraphy hand standardized ischemic exercise test . For purpose , Tc-99m-rh-annexin A5 ( 400 MBq ; &lt; 5 mSv ) inject intravenously upon reperfusion , follow scintigraphy hand gamma camera 1 4 hour injection . Annexin A5 target calculated percentage difference activity ( counts/pixel ) thenar muscle hand .</brief_summary>
	<brief_title>Rosuvastatin Ischemia Reperfusion</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy volunteer ( 1850 year age ) Hypercholesterolemia Hypertension</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Ischemia-reperfusion</keyword>
	<keyword>Annexin A5</keyword>
</DOC>